China Medical System Holdings Ltd
SWB:2M7C
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.641
1.79
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
China Medical System Holdings Ltd
Total Equity
China Medical System Holdings Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
China Medical System Holdings Ltd
SWB:2M7C
|
Total Equity
¥15.9B
|
CAGR 3-Years
9%
|
CAGR 5-Years
12%
|
CAGR 10-Years
16%
|
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Total Equity
HK$15.7B
|
CAGR 3-Years
9%
|
CAGR 5-Years
15%
|
CAGR 10-Years
33%
|
|
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Total Equity
¥13.5B
|
CAGR 3-Years
14%
|
CAGR 5-Years
16%
|
CAGR 10-Years
9%
|
|
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Total Equity
¥32.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
2%
|
CAGR 10-Years
22%
|
|
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Total Equity
HK$48.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
H
|
HUTCHMED (China) Ltd
HKEX:13
|
Total Equity
$740.1m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
16%
|
CAGR 10-Years
23%
|
|
China Medical System Holdings Ltd
Glance View
China Medical System Holdings Ltd. engages in the production, marketing, promotion, and sale of drugs. The company employs 5,622 full-time employees The company went IPO on 2010-09-28. The firm's products include Plendil, Ursofalk, Augentropfen Stulln Mono Eye Drops, Hirudoid, Atopic Piel Series and Vmonalisa, among others. Its major marketed products cover the cardio-cerebrovascular, gastroenterology, ophthalmology, dermatology and medical aesthetic fields. The firm distributes its products within domestic market and to overseas markets.
See Also
What is China Medical System Holdings Ltd's Total Equity?
Total Equity
15.9B
CNY
Based on the financial report for Jun 30, 2024, China Medical System Holdings Ltd's Total Equity amounts to 15.9B CNY.
What is China Medical System Holdings Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
16%
Over the last year, the Total Equity growth was 0%. The average annual Total Equity growth rates for China Medical System Holdings Ltd have been 9% over the past three years , 12% over the past five years , and 16% over the past ten years .
You don't have any saved screeners yet
